HomeAREVF • OTCMKTS
add
AREV Life Sciences Global Ord Shs
Previous close
$0.00050
Year range
$0.00050 - $0.010
Avg Volume
1.73K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 49.11K | -80.74% |
Operating expense | 1.42M | -22.45% |
Net income | -1.44M | -45.82% |
Net profit margin | -2.94K | -657.12% |
Earnings per share | — | — |
EBITDA | -1.31M | 15.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 94.00 | -99.94% |
Total assets | 252.63K | -59.42% |
Total liabilities | 1.21M | 68.31% |
Total equity | -952.61K | — |
Shares outstanding | 31.76M | — |
Price to book | -0.02 | — |
Return on assets | -198.35% | — |
Return on capital | 184.38% | — |
Cash Flow
Net change in cash
| (CAD) | 2022info | Y/Y change |
|---|---|---|
Net income | -1.44M | -45.82% |
Cash from operations | -283.89K | 80.69% |
Cash from investing | -81.81K | -1,412.50% |
Cash from financing | 207.43K | -84.47% |
Net change in cash | -158.22K | -13.57% |
Free cash flow | 20.19K | 103.22% |
